To content
Fakultät Bio- und Chemieingenieurwesen
© CBE​/​BCI

 

Prof. Sánchez-García was interviewed by the Bundesministerium für Forschung, Technologie und Raumfahrt (BMFTR) about the latest publication in Nature Communications. Together with Prof. Lisa Wiesmüller and Prof. Christof Gebhardt from Universitätsklinikum Ulm, the interview showcased the path to the in silico discovery of the peptide Ku3. This peptide has the potential to be use as an inhibitor of the unwanted pro-tumorigenic activity of the endonucease G (EndoG)  during chemotherapy, without affecting its standard cytotoxic activity in tumoral cells.

Interview: https://www.dekade-gegen-krebs.de/de/krebsforschung/aktuelles-aus-der-forschung/_documents/peptid-koennte-krebstherapien-sicherer-machen.html?nn=473182

Original paper: https://www.nature.com/articles/s41467-026-72034-2